Clinical trials in nuclear medicine: Present and future
| Titre | Clinical trials in nuclear medicine: Present and future |
| Type de publication | Article de revue |
| Auteur | Chaumet-Riffaud, P., Cachin, F., Couturier, Olivier-François , Desruet, M.-D., Kraeber-Bodéré, Françoise, Talbot, J.-N., Vuillez, J.-P. |
| Editeur | Elsevier Masson |
| Type | Article scientifique dans une revue à comité de lecture |
| Année | 2009 |
| Langue | Anglais |
| Date | 2009 |
| Numéro | 5 |
| Pagination | 296-304 |
| Volume | 33 |
| Titre de la revue | Medecine Nucleaire |
| ISSN | 0928-1258 |
| Mots-clés | 3' fluorothymidine f 18, article, benzamide derivative, breast cancer, Chemotherapy, Clinical research, clinical trial, Controlled trials, diagnostic procedure, fluorodeoxyglucose f 18, Human, lymphoma, medical research, Methodology, Nuclear Medicine, octreotide lu 177, Oncology, radiodiagnosis, radiopharmaceutical agent, Radiopharmaceuticals, unclassified drug, validation process, yttrium 90 |
| Résumé en anglais | The particular status of radiopharmaceuticals, together with the positioning of nuclear medicine in multidisciplinary approach of oncology, lead to real difficulties for conception, validation and granting of clinical trials which are necessary for demonstrating clinical interest of new compounds, for diagnosis as well as for therapeutic use. This article is a presentation of some recent clinical trials conducted in nuclear medicine in France, showing its dynamism but also pointing out some encountered difficulties. These experiences could lead to reflexion in order to improve the clinical research performances, taking into account a scientific and regulatory context more and more constraining. |
| URL de la notice | http://okina.univ-angers.fr/publications/ua3755 |
| DOI | 10.1016/j.mednuc.2009.03.001 |